Berwyn, Pa. – AMETEK, Inc. (NYSE: AME) today announced that it has entered into a definitive agreement to acquire a portfolio of instrumentation businesses from Indicor, LLC (“Indicor Instrumentation”) in an all‑cash transaction valued at approximately $5.0 billion. Indicor Instrumentation is a group of leading businesses that design and manufacture mission critical solutions for demanding industrial […]

GWACHEON, South Korea — Park Systems Corp., the world’s leading provider of atomic force microscopy (AFM) solutions, today announced the completion of its acquisition of Rocky Mountain Nanotechnology LLC (RMN), a Salt Lake City, Utah-based manufacturer of ultra-high-purity solid platinum and platinum-iridium AFM probes. The acquisition marks Park Systems’ first entry into probe manufacturing and represents […]

Luxembourg/New York/Paris – Astorg, a leading pan-European private equity firm, announces that it has signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific (or “the Company”). Through the transaction, Thermo Fisher’s microbiology business will become an independent, privately owned platform, backed by Astorg. Building on its deep healthcare sector expertise and […]

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides […]

Shimadzu Corporation has acquired a 75% stake of the outstanding shares of German startup Plasmion GmbH (headquartered in Augsburg, Bavaria) on March 23, making the company a subsidiary. This acquisition aims to obtain Plasmion’s mass spectrometer (MS) ion source technology SICRIT(Soft Ionization by Chemical Reaction In Transfer)※ and related technologies to strengthen Shimadzu’s MS business. SICRIT […]

COLUMBUS, Ohio–Innovative Lab Services LLC (“ILS”), a leading provider of analytical instrument services, today announced the acquisition of Analytical Instrument Management (“AIM”), a leading provider of refurbished analytical instrumentation. The acquisition significantly expands ILS’s capabilities in equipment sales, enabling the combined platform to deliver a full lifecycle solution for laboratory customers. ILS now provides high-quality […]

Acquisition of CareDx’s ‘lab products’ portfolio creates new opportunities for growth and innovation in the fast growing transplant diagnostics market Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leader Creation of a global leading provider of kits for transplantation genomics Acquisition of a 100% proprietary products portfolio Deeper capabilities and larger […]

DKSH has closed an agreement to acquire the business of Kinematic Resources Sdn. Bhd. (“Kinematic”), a leading Malaysian distributor of high-value scientific and analytical instruments in Malaysia. With this transaction, DKSH Technology further scales its operations in Malaysia in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider […]

Transaction Expected to Sharpen CareDx’s Focus on Core Precision Medicine Testing Services and Patient and Digital Solutions, Improve Financial Flexibility, Simplify Operating Model, and Support AEBITDA Margin Expansion Expects First Quarter Testing Services Revenue Growth of Approximately 48% Year Over Year, Testing Volume Growth of Approximately 17% Year-Over-Year BRISBANE, Calif. — CareDx, Inc. (Nasdaq: CDNA) […]

New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. […]